Registry of Lobbyists
Active
-
Last Updated:
2024-07-19
| Subject matters | Details | Categories |
|---|---|---|
|
Health
|
Engagement with officials on Bill S-280, An Act respecting a national framework on sickle cell disease, to discuss measures and initiatives to improve care and treatment of Canadians affected by sickle cell disease and increase public awareness of the disease.
|
Legislative Proposal, Bill or Resolution
|
|
Budget,
Health
|
Federal programs and budgetary initiatives related to the Federal-Provincial-Territorial funding arrangements regarding pharmaceuticals.
|
Policies or Program
|
|
Health
|
Federally-funded Public Drug Plans, with respect to reimbursement for drug products for federal plan beneficiaries.
|
Policies or Program
|
|
Health
|
Guidelines, policies and programs related to regulatory and reporting functions of the Patented Medicine Prices Review Board
|
Policies or Program,
Regulation
|
|
Health,
Industry
|
Innovation, Science and Economic Development Canada and Innovation Agenda, Science and Technology Strategy, or other Government policy or program initiatives to support research and development activities in Canada.
|
Policies or Program
|
|
Health
|
Proposals to amend guidelines related to the operationalization of the legislation and regulations governing the Patented Medicine Prices Review Board
|
Policies or Program
|
|
Health
|
Regulatory amendments and/or guidelines related to the Food and Drugs Act Regulations and Health Canada review processes to implement an orphan drug regulatory framework.
|
Policies or Program,
Regulation
|
|
Health
|
The development of a national pharmacare program, including the Canada Drug Agency, a national formulary and a rare diseases strategy
|
Policies or Program
|
Communication techniques that have been used or are expected to be used in the course of the undertaking:
| Date | DPOH, Position Title | Government Institution | Subject Matters |
|---|---|---|
| 2024-06-20 |
|
Budget, Health, Industry |